Overactive Bladder
📧 Sign up to get email alerts when something new happens for Overactive Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: Clinical Feasibility Study, Implantable Tibial Nerve Stimulator (ITNS) [NA]
Clinical feasibility study for an implantable tibial nerve stimulator in overactive bladder has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: Feasibility of Parasacral Transcutaneous Electrical Nerve Stimulation PTENS for Voiding Dysfunction in Peds Population [NA]
Clinical trial update on feasibility of parasacral transcutaneous electrical nerve stimulation (PTENS) for voiding dysfunction in pediatric …
-
CLINICAL_TRIALS trial_result · 2022-02-22Clinical Trial Update: Tolterodine Relieves Overactive Bladder Symptoms in Women With Moderate-to-severe Obstructive Sleep Apnea Syndrome [Phase 4]
A Phase 4 trial suggests tolterodine may relieve symptoms of overactive bladder in women with moderate-to-severe obstructive sleep apnea.
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in Children [Phase 1, Phase 2]
Clinical trial update for beta 3 agonists exploring treatment of voiding disorders and overactive bladder in children, currently in Phase 1/…
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: OnabotulinumtoxinA Bladder Injection Study [Phase 4]
Phase 4 trial of onabotulinumtoxinA injected into the bladder for overactive bladder has been terminated; results posted in 2022.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-01-28Clinical Trial Update: To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive Bladder [Phase 3]
Phase 3 trial evaluating JLP-2002 for efficacy and safety in overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2022-01-12Clinical Trial Update: Sequencing and Combination of Mirabegron and TTNS in Overactive Bladder Syndrome: a Multicenter, Randomized, Open-label, Crossover Trial [Phase 4]
A multicenter, randomized, open-label, crossover Phase 4 trial evaluating sequencing and combination of mirabegron and TTNS for overactive b…
-
CLINICAL_TRIALS trial_result · 2021-12-15Clinical Trial Update: Comparing Number of Injection Sites of In-office Intravesical Onabotulinumtoxin A Treatments for Overactive Bladder: A Randomized Controlled Trial [Phase 4]
Phase 4 randomized trial comparing number of injection sites for in-office intravesical onabotulinumtoxinA in overactive bladder.
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: InterStim Basic Evaluation Lead Post-Market Clinical Follow-up Study [NA]
Completed post-market follow-up study for InterStim basic evaluation lead in patients with overactive bladder and urinary urge incontinence;…
-
CLINICAL_TRIALS trial_result · 2021-10-14Clinical Trial Update: BOTOX® at the Time of Prolapse Surgery for OAB [Phase 4]
Phase 4 clinical trial update evaluating Botox at the time of prolapse surgery for overactive bladder symptoms.
-
CLINICAL_TRIALS trial_result · 2021-10-06Clinical Trial Update: Comparison of Motor and Sensory Response With Interstim Stimulation [NA]
Completed clinical trial comparing motor and sensory response with interstim stimulation for overactive bladder and urgency-frequency; resul…
-
CLINICAL_TRIALS trial_result · 2021-09-23Clinical Trial Update: Investigation of the Effect of the Female Urinary Microbiome on Incontinence [Phase 4]
Phase 4 trial investigating the effect of the female urinary microbiome on urinary incontinence outcomes has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-16Clinical Trial Update: A Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease (MAESTRO) [Phase 4]
Pilot Phase 4 trial evaluating mirabegron plus pelvic floor exercise for overactive bladder symptoms in Parkinson's disease; results posted …
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence [Phase 2]
Phase 2 clinical trial evaluating intravesical Botox (onabotulinumtoxinA) for overactive bladder with urinary incontinence has completed wit…
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder [Phase 4]
Phase 4 clinical trial update investigating a beta-3 agonist and an anti-muscarinic agent for Sjogren's syndrome with overactive bladder.
-
CLINICAL_TRIALS trial_result · 2021-07-30Clinical Trial Update: Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence [NA]
This update reports the completion and posted results of a pivotal clinical trial evaluating eCoin for overactive bladder with urgency urina…
-
CLINICAL_TRIALS trial_result · 2021-06-16Clinical Trial Update: Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2 [Phase 3]
A Phase 3 study evaluating Dysport (abobotulinumtoxinA) for urinary incontinence due to neurogenic detrusor overactivity in adults with spin…
-
CLINICAL_TRIALS trial_result · 2021-05-19Clinical Trial Update: Safety and Efficacy of MK0594 to Treat Overactive Bladder (0594-003) [Phase 2]
Phase 2 trial update on MK0594 for overactive bladder showed safety and efficacy data.
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: eCoin for OAB Feasibility Follow-on Study [NA]
A completed feasibility follow-on study of eCoin for overactive bladder and urge urinary incontinence; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-15Clinical Trial Update: The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial Peptides [NA]
A completed clinical trial studying the estrogen impact on female pelvic floor microbiomes and antimicrobial peptides in overactive bladder …
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia. [Phase 4]
Phase 4 trial update evaluating efficacy and safety of a combination therapy for overactive bladder in male patients with benign prostatic h…
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) [Phase 3]
Phase 3 trial completed evaluating a new drug for overactive bladder; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB). [Phase 3]
A Phase 3 extension study evaluated the safety and tolerability of a new drug in patients with symptoms of overactive bladder; study complet…
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication. [Phase 4]
Phase 4 trial evaluating Detrol LA with behavioral intervention for patients with overactive bladder who were dissatisfied with prior OAB me…
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women [Phase 4]
Phase 4 trial update evaluating Detrol LA effects on overactive bladder symptoms, sexual quality of life, and sexual function in women.